Venture Capital Sneak Peek: 2016 Year‑in‑Review
The CVCA will be publishing its final 2016 Year-in-Review VC + PE Canadian Market Overview mid February. As expected, the preliminary VC data continues a very positive trajectory with more than $2.8B disbursed in 2016. Not only is that already 19% higher than 2015, it is more than was disbursed in any year since 2002 ($2.7B). Look forward to the complete CVCA trend analysis by sector/province. In the meantime, here is a long-term chart that puts into context the steady year-over-year growth in Canadian VC disbursements.
Activity in 2016 was marked by the return of mega-deals; there were 4 deals greater than $100M in 2016 versus none in 2015. iNovia Capital was a co-investor in the $158M Thalmic Labs, the largest deal of the year, followed by the $150M Medgate financing in which Georgian Partners, BMO Capital Partners and Teralys Capital co-invested. The total of the top 10 deals in 2016 amounted to $984M, double the total of the top 10 from the previous year ($486M). Worth noting that 7 out of the largest 102016 deals were greater than the largest deal from the previous year ($79M Lightspeed POS round).
